CDC Broke Gilead HIV Research Deal, Claims Court Rules
IP Law 360
NOVEMBER 30, 2022
Court of Federal Claims on Wednesday unsealed its ruling finding that the Centers for Disease Control and Prevention violated research agreements with Gilead Sciences by failing to notify the drugmaker about patents the agency had filed to cover HIV treatments.
Let's personalize your content